Table 1.
Case | Eye | Tumor no. | Prior treatment | Clinical regression pattern |
---|---|---|---|---|
1 | OD | 1 | None | None |
2 | OS | 1 | Systemic chemotherapy (2 cycles) and TTT (2 sessions) | 3 |
OS | 2 | Systemic chemotherapy (2 cycles) and TTT (2 sessions) | 3 | |
3 | OS | 1 | Systemic chemotherapy (6 cycles), IAC (2 rounds), TTT (5 sessions), and TTT (2 sessions over relapse area) | 3 |
4 | OD | 1 | Systemic chemotherapy (3 cycles) and TTT (1 session) | 2 |
OD | 2 | Systemic chemotherapy (3 cycles) and TTT (1 session) | 4 | |
OS | 1 | Systemic chemotherapy (3 cycles) and TTT (1 session) | 3 | |
5 | OS | 1 | IAC (3 rounds) and TTT (4 sessions) | 3 |
6 | OS | 1 | IAC (2 rounds) and TTT (3 sessions) | 3 |
Systemic chemotherapy: vincristine, etoposide, and carboplatin. TTT, transpupillary thermotherapy; IAC, intra-arterial chemotherapy (melphalan).